Cargando…

Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study

OBJECTIVE: To understand the epidemiology and burden of severe coronavirus disease 2019 (covid-19) during the first epidemic wave on the west coast of the United States. DESIGN: Prospective cohort study. SETTING: Kaiser Permanente integrated healthcare delivery systems serving populations in norther...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewnard, Joseph A, Liu, Vincent X, Jackson, Michael L, Schmidt, Mark A, Jewell, Britta L, Flores, Jean P, Jentz, Chris, Northrup, Graham R, Mahmud, Ayesha, Reingold, Arthur L, Petersen, Maya, Jewell, Nicholas P, Young, Scott, Bellows, Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243800/
https://www.ncbi.nlm.nih.gov/pubmed/32444358
http://dx.doi.org/10.1136/bmj.m1923
_version_ 1783537472913801216
author Lewnard, Joseph A
Liu, Vincent X
Jackson, Michael L
Schmidt, Mark A
Jewell, Britta L
Flores, Jean P
Jentz, Chris
Northrup, Graham R
Mahmud, Ayesha
Reingold, Arthur L
Petersen, Maya
Jewell, Nicholas P
Young, Scott
Bellows, Jim
author_facet Lewnard, Joseph A
Liu, Vincent X
Jackson, Michael L
Schmidt, Mark A
Jewell, Britta L
Flores, Jean P
Jentz, Chris
Northrup, Graham R
Mahmud, Ayesha
Reingold, Arthur L
Petersen, Maya
Jewell, Nicholas P
Young, Scott
Bellows, Jim
author_sort Lewnard, Joseph A
collection PubMed
description OBJECTIVE: To understand the epidemiology and burden of severe coronavirus disease 2019 (covid-19) during the first epidemic wave on the west coast of the United States. DESIGN: Prospective cohort study. SETTING: Kaiser Permanente integrated healthcare delivery systems serving populations in northern California, southern California, and Washington state. PARTICIPANTS: 1840 people with a first acute hospital admission for confirmed covid-19 by 22 April 2020, among 9 596 321 healthcare plan enrollees. Analyses of hospital length of stay and clinical outcomes included 1328 people admitted by 9 April 2020 (534 in northern California, 711 in southern California, and 83 in Washington). MAIN OUTCOME MEASURES: Cumulative incidence of first acute hospital admission for confirmed covid-19, and subsequent probabilities of admission to an intensive care unit (ICU) and mortality, as well as duration of hospital stay and ICU stay. The effective reproduction number (R(E)) describing transmission dynamics was estimated for each region. RESULTS: As of 22 April 2020, cumulative incidences of a first acute hospital admission for covid-19 were 15.6 per 100 000 cohort members in northern California, 23.3 per 100 000 in southern California, and 14.7 per 100 000 in Washington. Accounting for censoring of incomplete hospital stays among those admitted by 9 April 2020, the estimated median duration of stay among survivors was 9.3 days (with 95% staying 0.8 to 32.9 days) and among non-survivors was 12.7 days (1.6 to 37.7 days). The censoring adjusted probability of ICU admission for male patients was 48.5% (95% confidence interval 41.8% to 56.3%) and for female patients was 32.0% (26.6% to 38.4%). For patients requiring critical care, the median duration of ICU stay was 10.6 days (with 95% staying 1.3 to 30.8 days). The censoring adjusted case fatality ratio was 23.5% (95% confidence interval 19.6% to 28.2%) among male inpatients and 14.9% (11.8% to 18.6%) among female inpatients; mortality risk increased with age for both male and female patients. Reductions in R(E) were identified over the study period within each region. CONCLUSIONS: Among residents of California and Washington state enrolled in Kaiser Permanente healthcare plans who were admitted to hospital with covid-19, the probabilities of ICU admission, of long hospital stay, and of mortality were identified to be high. Incidence rates of new hospital admissions have stabilized or declined in conjunction with implementation of social distancing interventions.
format Online
Article
Text
id pubmed-7243800
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72438002020-06-03 Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study Lewnard, Joseph A Liu, Vincent X Jackson, Michael L Schmidt, Mark A Jewell, Britta L Flores, Jean P Jentz, Chris Northrup, Graham R Mahmud, Ayesha Reingold, Arthur L Petersen, Maya Jewell, Nicholas P Young, Scott Bellows, Jim BMJ Research OBJECTIVE: To understand the epidemiology and burden of severe coronavirus disease 2019 (covid-19) during the first epidemic wave on the west coast of the United States. DESIGN: Prospective cohort study. SETTING: Kaiser Permanente integrated healthcare delivery systems serving populations in northern California, southern California, and Washington state. PARTICIPANTS: 1840 people with a first acute hospital admission for confirmed covid-19 by 22 April 2020, among 9 596 321 healthcare plan enrollees. Analyses of hospital length of stay and clinical outcomes included 1328 people admitted by 9 April 2020 (534 in northern California, 711 in southern California, and 83 in Washington). MAIN OUTCOME MEASURES: Cumulative incidence of first acute hospital admission for confirmed covid-19, and subsequent probabilities of admission to an intensive care unit (ICU) and mortality, as well as duration of hospital stay and ICU stay. The effective reproduction number (R(E)) describing transmission dynamics was estimated for each region. RESULTS: As of 22 April 2020, cumulative incidences of a first acute hospital admission for covid-19 were 15.6 per 100 000 cohort members in northern California, 23.3 per 100 000 in southern California, and 14.7 per 100 000 in Washington. Accounting for censoring of incomplete hospital stays among those admitted by 9 April 2020, the estimated median duration of stay among survivors was 9.3 days (with 95% staying 0.8 to 32.9 days) and among non-survivors was 12.7 days (1.6 to 37.7 days). The censoring adjusted probability of ICU admission for male patients was 48.5% (95% confidence interval 41.8% to 56.3%) and for female patients was 32.0% (26.6% to 38.4%). For patients requiring critical care, the median duration of ICU stay was 10.6 days (with 95% staying 1.3 to 30.8 days). The censoring adjusted case fatality ratio was 23.5% (95% confidence interval 19.6% to 28.2%) among male inpatients and 14.9% (11.8% to 18.6%) among female inpatients; mortality risk increased with age for both male and female patients. Reductions in R(E) were identified over the study period within each region. CONCLUSIONS: Among residents of California and Washington state enrolled in Kaiser Permanente healthcare plans who were admitted to hospital with covid-19, the probabilities of ICU admission, of long hospital stay, and of mortality were identified to be high. Incidence rates of new hospital admissions have stabilized or declined in conjunction with implementation of social distancing interventions. BMJ Publishing Group Ltd. 2020-05-22 /pmc/articles/PMC7243800/ /pubmed/32444358 http://dx.doi.org/10.1136/bmj.m1923 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Lewnard, Joseph A
Liu, Vincent X
Jackson, Michael L
Schmidt, Mark A
Jewell, Britta L
Flores, Jean P
Jentz, Chris
Northrup, Graham R
Mahmud, Ayesha
Reingold, Arthur L
Petersen, Maya
Jewell, Nicholas P
Young, Scott
Bellows, Jim
Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
title Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
title_full Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
title_fullStr Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
title_full_unstemmed Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
title_short Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
title_sort incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in california and washington: prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243800/
https://www.ncbi.nlm.nih.gov/pubmed/32444358
http://dx.doi.org/10.1136/bmj.m1923
work_keys_str_mv AT lewnardjosepha incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT liuvincentx incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT jacksonmichaell incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT schmidtmarka incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT jewellbrittal incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT floresjeanp incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT jentzchris incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT northrupgrahamr incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT mahmudayesha incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT reingoldarthurl incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT petersenmaya incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT jewellnicholasp incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT youngscott incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy
AT bellowsjim incidenceclinicaloutcomesandtransmissiondynamicsofseverecoronavirusdisease2019incaliforniaandwashingtonprospectivecohortstudy